Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
PLEASANTON, Calif. - Healthcare Triangle, Inc. (NASDAQ:HCTI), a digital transformation solutions provider for healthcare and life sciences with a market capitalization of $23.65 million, announced it will implement a 1-for-249 reverse stock split effective August 1, 2025. According to InvestingPro data, the stock has shown significant volatility, gaining over 100% in the past week despite poor long-term performance.
The company’s common stock will continue trading on the Nasdaq Capital Market under the same HCTI symbol but with a new CUSIP number (42227W 306). Trading on a post-split basis will commence at market opening on Friday, according to the press release statement.
The reverse split will reduce Healthcare Triangle’s outstanding common shares from approximately 1.45 billion to 5.83 million. The company indicated the move is part of its strategy to regain compliance with Nasdaq’s $1.00 minimum bid price requirement.
At the effective time, each 249 shares of issued and outstanding common stock will automatically convert to one share, with no change to the $0.00001 par value or total authorized shares. Stockholders entitled to fractional shares will have their holdings rounded up.
The reverse split was approved by stockholders at a special meeting held on February 26, 2025. VStock Transfer, LLC will provide information to stockholders of record regarding their post-split share ownership.
Healthcare Triangle provides services including cloud enablement, data analytics and managed services to hospitals, health systems, payers, and pharmaceutical companies. The company generated revenue of $11.29 million in the last twelve months. Get access to 10+ additional exclusive InvestingPro Tips and comprehensive financial analysis to make informed investment decisions.
In other recent news, Healthcare Triangle, Inc. has announced the completion of its acquisition of Niyama Healthcare and Ezovion Solutions, a transaction valued at $5.7 million. This acquisition was executed through its subsidiary, QuantumNexis, and includes cash payments and restricted common stock. The company has also launched QuantumNexis, a new subsidiary focused on AI-powered healthcare solutions, which was introduced at an event in Kuala Lumpur, Malaysia. Additionally, Healthcare Triangle is implementing a cost optimization initiative aimed at reducing annual expenses by up to $1.8 million.
The company has secured continued listing on the Nasdaq Stock Market after a review by the Nasdaq Hearings Panel, though it must meet certain conditions, including a reverse stock split by August 2025. Despite this, Healthcare Triangle faces potential delisting from Nasdaq due to its low stock price, having previously received a notice for not meeting the Minimum Bid Price Requirement. The firm must maintain a $1 closing bid price for 20 consecutive trading days by September 2025 to comply with Nasdaq’s rules. These developments highlight Healthcare Triangle’s strategic moves to strengthen its financial position and expand its technological offerings.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.